Clinical Trials in Chicago

Showing 5841-5860 of 20,493 trials

Safety and Feasibility of ExoNET

NCT05180812

The purpose of this study is to evaluate the safety, feasibility, and preliminary efficacy of the ExoNET passive robotic device. It will provide upper-extremity gravity compensation for therapeutic movement retraining in the chronic post stroke patient population.

StrokeCerebral Vascular Accident

Shirley Ryan AbilityLab20 participantsStarted Mar 2022

Chicago, Illinois, United States

Active Not Recruiting2.2 miles

Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy

NCT02633943

This is a multi-center, long-term safety and efficacy follow-up study for subjects with transfusion-dependent β-thalassemia (TDT) who have been treated with ex vivo gene therapy drug product in bluebird bio-sponsored parent clinical studies. After completing the parent clinical studies (approximately 2 years), eligible subjects will be followed for an additional 13 years for a total of 15 years post-drug product infusion. No investigational drug product will be administered in this study.

Transfusion-dependent Beta-Thalassemia

Genetix Biotherapeutics Inc.66 participantsStarted Jan 2014

Oakland, California, United States • Chicago, Illinois, United States • Bethesda, Maryland, United States +12 more locations

Safety and Feasibility of ExoNET

Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy

Find Trials by Condition in Chicago

Technology Enabled Services to Enhance Depression Care

A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX)

Applying Directly Observed Therapy to Hydroxyurea to Realize Effectiveness

Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma

Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs

REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma

Tau PET Imaging in Atypical Dementias

Effect of Acute Intake of Meals Containing Higher vs. Lower Energy From Protein on DIT

AB-1002 in Patients With Class III Heart Failure

A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors

Comparing Ankle Fusion to Ankle Replacement

Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53

A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines

Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2)

Long Term Follow-up of HPV Vaccine in HIV (CTN 236)

Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors

Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma